American company Symphony Robotics has introduced an innovative micro-robotic platform, licensed from Case Western Reserve University. This cutting-edge technology combines micromanipulators, computer vision, and AI, opening new frontiers in minimally invasive surgery.
📌 What does this mean?
✅ Ultra-precise operations with magnetic control through MRI
✅ Minimized incisions and craniotomies—down to 4mm instead of 40mm
✅ Access to hard-to-reach areas of the brain for treating glioblastoma (GBM) and epilepsy
✅ Reduced risk of damage to healthy tissues
This groundbreaking technology allows surgeons to precisely target tumors in challenging brain regions, minimizing trauma and accelerating patient recovery. The platform is currently undergoing testing in leading U.S. clinics and has not yet received FDA approval.
Symphony Robotics CEO Moti Avisar calls this a “revolution in neurosurgery”, as the robotic system enables unprecedented precision, using natural anatomical pathways instead of large incisions.
🔗 Learn more: Symphony Robotics 🚀
